Lathyrogens decrease collagen and elastin cross-linking by inhibiting lysine oxidase. The lathyrogens isoniazid and semicarbazide decrease liver pyridoxal phosphate and are teratogenic; all their effects are reversed by pyridoxal. ,-Aminopropionitrile, another lathyrogen, does not affect liver pyridoxal phosphate, and its lathyrogenic and teratogenic effects are not reversed by pyridoxal. Time courses of these effects differ greatly, suggesting enzyme inhibition by different mechanisms.
INTRODUCTION
A lathyrogen is a compound which prevents the cross-linking of collagen and elastin in vivo by inhibiting lysine oxidase (protein-lysine 6-oxidase, EC 1.4.3.13).
This enzyme acts by oxidatively deaminating the e-amino groups of certain lysine and hydroxylysine residues, resulting in the formation of their aldehydic derivatives. These can then cross-link non-enzymically with specific lysine or hydroxylysine residues in neighbouring collagen chains and molecules, by Schiff-base formation or by more stable aldol condensations, to give collagen its tensile properties (Bailey, 1968; Robins, 1982) . Similar reactions occur in the cross-linking of elastin (Partridge et al., 1964) . The enzyme has two obligatory cofactors, i.e. copper (Miller et al., 1965; Cames, 1971; Harris & O'Dell, 1974 ) and a pyridoxal derivative (Murray & Levene, 1977; Murray et al., 1978; Bird & Levene, 1982 . The changes in a lathyritic chick embryo include striking fragility of the connective tissues and an increase in the salt-solubility of collagen and elastin; these may result in avulsion of tendon from bones, slipping of epiphyses, subluxation of the lenses of the eyes from their suspensory ligaments, severe skeletal deformity and, often, death from aortic rupture.
During a study of the mode of action of lathyrogens (Levene, 1961a) , four separate chemical groups were identified (Table 1) . These four groups share the property of being carbonyl-blocking agents. Pyridoxal was able to antagonize the lathyrogenic effect of isoniazid (INAH) in the chick embryo in vivo (Levene, 1961b (Levene, , 1962 
EXPERIMENTAL Incubation and injection of fertile eggs
Fertile eggs were incubated at 37°C in a humid atmosphere with periodic turning until they were used for experiments; embryos were generally incubated for 14 days before being used. Drugs were dissolved in distilled water, and 0.1 ml of solution was injected through a pin-hole in the shell. Most injections were administered after 14 and 15 days of incubation and the embryos harvested on day 16, except in the time-course experiment, when they were harvested at the stated times. Into each egg 6.0 mg of SCH and 11.0 mg of pyridoxal (Kagan et al., 1974) of the method of Pinnell & Martin (1968 Control embryos (El) were not injected. All lathyrogens were dissolved in 0.1 ml of distilled water. Leg bones were removed at intervals, and PBS extracts were assayed for hydroxyproline (a) and lysine oxidase (b). treated with lathyrogens therefore do not appear to affect the assays (Table 3) .
A 72 h time course of the effect of INAH, SCH and BAPN was performed on groups of embryos to explore any possible variations in behaviour. Extractable hydroxyproline, cartilage and bone lysine oxidase activity and liver pyridoxal phosphate values were estimated at 6, 12, 24, 36, 48 and 72 h after the original 14-day injection. The results (Fig. 1, Table 4 ) confirm our previous findings (Carrington et al., 1984) that INAHtreated embryos fail to recover anything like as well as BAPN-treated embryos by 24 h, but also show clearly that SCH-treated embryos behavejust like INAH-treated embryos in regard to recovery and totally unlike BAPN-treated embryos.
DISCUSSION
As a result of earlier work and these new SCH data, we are now clearer about the mechanisms of action of these three lathyrogens. Our first experiment confirms earlier experiments (Carrington et al., 1984) that INAH both increases collagen solubility in the chick embryo and lowers cartilage and bone lysine oxidase activity and liver pyridoxal phosphate content; treatment with pyridoxal reverse these three effects.
The present study clearly shows that SCH, a ureide, behaves just like INAH, a hydrazide; when injected into the chick embryo, pyridoxal phosphate reverses these three effects. BAPN, however, although increasing collagen solubility and lowering cartilage and bone lysine oxidase activity, has no effect on liver pyridoxal phosphate content; moreover, treatment with pyridoxal fails to reverse the increase in collagen solubility and the fall in cartilage lysine oxidase activity.
Certain lathyrogens, when injected into much younger chick embryos (4 days of incubation instead of 14 days) have been shown to produce severe teratogenic changes in the skeleton; these compounds include BAPN, SCH and two members of the hydrazide group (Levene, 1961b) . Pyridoxal treatment has been shown to be able to inhibit the deformities produced by the SCH and the hydrazide compounds, but has not effect on BAPNinduced deformities (Levene, 1961a) . These results reinforce the view that BAPN acts in a different manner from the other lathyrogens mentiond above, although the end result on collagen cross-linking is the same for all of these compounds.
The time-course studies on these various lathyrogens also indicate a fundamental difference in their behaviour; our data indicate that the failure of SCH-treated chick embryos to recover to more than 10% of their original lysine oxidase activity by 72 h after treatment suggests that SCH acts in the same way as INAH; the behaviour of both of these compounds differs markedly from that of BAPN, where recovery commences within 24 h. One explanation is that BAPN acts at one site on the enzyme, whereas SCH and INAH act at a different site. We believe that the last two compounds act by displacing the pyridoxal cofactor with which both compounds can form hydrazones. We have previously shown that loss of an essential cofactor can lead to the degradation of the apoenzyme (Murray & Levene, 1977) , resulting in a delay of collagen cross-linking until new enzyme synthesis has occurred and the essential cofactor has been replaced. BAPN, on the other hand, appears to block the active site on the enzyme irreversibly (Pinnell & Martin, 1968; Tang et al., 1983) , and recovery occurs fairly rapidly, presumably owing to synthesis of the enzyme de novo, the pyridoxal cofactor still being available; it will be recalled that BAPN does not decrease liver pyridoxal phosphate. Tang et al. (1983) have shown that BAPN binds to the enzyme covalently, inactivation being proportional to the amount of BAPN bound. They have also shown that BAPN is not processed to a free aldehyde product on incubation with the enzyme.
A major difficulty concerning this enzyme has been its confusion with other amine oxidases; we therefore wish to make a point about amine oxidases in general. They occur in several different classes, and one of the major problems in connection with them is to know their true substrates; the physiological substrates of lysine oxidase are collagen and elastin. This is not true of the majority of monoamine oxidases, which do not effect collagen or elastin cross-link formation. However, a monoamine oxidase, previously known as 'clorgyline-resistant amine oxidase' (Lyles et al., 1983) , has been isolated from the brown fat of rats. Unlike other monoamine oxidases, it is inhibited by SCH (Barrand & Callingham, 1982 , and has consequently been renamed 'semicarbazidesensitive monoamine oxidase'. Treatment of mice with SCH has also been shown to lower the amount of pyridoxal phosphate in the brain (Sakurai et al., 1981) .
It would clearly be of interest to see whether an amine oxidase such as that found in the rat's brown fat bears a relationship to lysine oxidase. It is likely that this type of study would enable one to draw conclusions concerning mechanism of action.
